Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years.
Launched by HOSPITAL DEL MAR · Jan 18, 2024
Trial Information
Current as of March 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Computed Tomography (CT) is widely used in stable patients with PAT and it requires intravenous contrast and patient irradiation, leading to additional costs to healthcare services. This study aims to assess the management of PAT in our institution and with its results review the actual protocol.
A retrospective unicentric st...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All penetrating trauma patients admitted in the emergency department.
- Exclusion Criteria:
- • All patients with any other diagnostic different from penetrating trauma
- • Blunt trauma patients admitted in the emergency department
Trial Officials
Ana María González Castillo, PhD
Principal Investigator
Hospital del Mar
About Hospital Del Mar
Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0